Skip to main content
. 2004 Feb;88(2):199–203. doi: 10.1136/bjo.2003.018234

Figure 1.

Figure 1

Study design. (1) Timing of screening visit 2–4 weeks before the baseline visit. (2) Baseline visit with randomisation and treatment initiation. (3) Fixed combination of latanoprost 0.005% and timolol 0.5%.